Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/1990
09/26/1990EP0270545B1 Medicinal composition
09/26/1990EP0245322B1 A composition for treating and preventing diarrhoea in humans and animals and a method of preparing same
09/26/1990EP0229564B1 Glycoproteins modified by oxidation followed by reduction, which inhibit ribosomes, production process and immunotoxines containing such a glycoprotein
09/26/1990CN1045586A Peptides
09/25/1990US4959458 Hybrid cell line for producing monoclonal antibody to a human monocyte antigen, antibody, and methods
09/25/1990US4959457 Monoclonal antibody
09/25/1990US4959455 Primate hematopoietic growth factors IL-3 and pharmaceutical compositions
09/25/1990US4959372 Anti-hypertensive substituted 2-azabicyclooctane-3-carboxylic acids
09/25/1990US4959358 Drug administration
09/25/1990US4959354 Follicle stimulating hormone, lutenizing hormone, inducing superovulation in cows, sheep, goats
09/25/1990US4959353 Promotion of corneal stroma wound healing with human epidermal growth factor prepared from recombinant DNA
09/25/1990US4959352 Cyclic growth hormone releasing factor analogs and method for the manufacture thereof
09/25/1990US4959351 Crystal suspensions of insulin derivatives, processes for their preparation and their use
09/25/1990US4959350 Enteral diet product and agent for production thereof
09/25/1990US4959320 Monoclonal antibody, process for preparing same, reagent for detecting cancer antigen containing the monoclonal antibody and process for preparing same
09/25/1990US4959314 Mutants of active proteins, replacing cysteine
09/25/1990US4959218 Method for delivering somatotropin to an animal
09/25/1990US4959217 Delayed/sustained release of macromolecules
09/25/1990US4959213 Pharmaceutical composition for treatment and/or prevention of diseases of the skin involving an inflammatory process
09/25/1990US4959210 Treatment of genital warts with a combination of liquid nitrogen and recombinant DNA human alpha interferon
09/25/1990US4959175 Solution for dialyses and use of peptides based on glycine for preparing it
09/25/1990CA1274471A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
09/24/1990WO1990011301A1 Human macrophage migration inhibitory factor
09/23/1990WO1990011295A1 Melanin-concentrating hormones and methods of treatment using same
09/21/1990WO1990011350A1 Human monoclonal antibody reactive with pseudomonas aeruginosa, cell which produces the antibody, method of production, and pharmaceutical preparation
09/21/1990WO1990011299A1 Novel insulin compounds
09/21/1990CA2049961A1 Insulin compounds
09/21/1990CA2028815A1 Human monoclonal antibodies having reactivity with pseudomonas aeruginosa, cells capable of producing the same, methods for production thereof and pharmaceutical preparations thereof
09/21/1990CA2012720A1 Genetically engineered human cholinesterases
09/20/1990WO1990010872A1 Extraction and use of a rna proteo-lipid complex contained in malignant human cells
09/20/1990WO1990010706A1 Acetylated heterologous polypeptides
09/20/1990WO1990010700A1 Modified antibodies
09/20/1990WO1990010699A1 MOLECULAR CLONING OF GENOMIC AND cDNA SEQUENCES ENCODING CELLULAR RECEPTORS FOR POLIOVIRUS
09/20/1990WO1990010692A1 Monoclonal antibody for use in detection and treatment of childhood leukemia
09/20/1990WO1990010650A1 Cytokine
09/20/1990WO1990010461A1 A uv-induced factor for immunosuppression
09/20/1990WO1990010459A1 Pharmaceutical composition useful in the prevention or treatment of papillomavirus-induced tumours
09/20/1990WO1990010456A1 Fibroblast growth factor (fgf)-based stabilized compositions
09/20/1990WO1990010455A1 Products containing a lithium salt and a tumour necrosis factor
09/20/1990WO1990010453A1 Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma
09/20/1990WO1990010452A1 Protein fraction from the photosynthesis apparatus of plants for use as an active substance in the selective destruction of cancer cells and the post-treatment of scars, keloids and inflammatory processes and pharmaceutical products containing it
09/20/1990WO1990006047A3 Human high-affinity neurotransmitter uptake system
09/20/1990CA2050319A1 Uv-induced factor for immunosuppression
09/19/1990EP0388226A2 Means for the treatment of senile dementia, memory disorders and related conditions
09/19/1990EP0388223A2 Novel method of ovulation induction in humans
09/19/1990EP0388151A1 Modified antibodies
09/19/1990EP0387945A1 A composition for the treatment of exocrine insufficiency of the pancreas, and the use of said composition
09/19/1990EP0387915A1 F antigens of the human immunodeficiency virus, and their applications
09/19/1990EP0387914A1 Envelope antigens of the human immuno-deficiency virus, and their applications
09/19/1990EP0387850A1 ECA-specific monoclonal antibodies and their use
09/19/1990EP0387775A1 Genetic construct for inhibiting RNA function
09/19/1990EP0387701A1 Use of intercellular adhesion molecules, and their binding ligands in the treatment of asthma
09/19/1990EP0387668A1 Intercellular adhesion molecule - 2 and its binding ligands
09/19/1990EP0387457A1 Recombinant fish hormone proteins
09/19/1990EP0387380A1 Mutants of urinary plasminogen activator, their production and use
09/19/1990EP0362218A4 Improved method for producing factor viii:c-type proteins
09/19/1990EP0342206A4 Human interleukin-3 proteins
09/18/1990WO1990011367A1 IMMUNOGLOBULIN A1 PROTEASES (IgA1 PROTEASES), METHOD OF GENE-TECHNOLOGICALLY PRODUCING THIS TYPE OF ENZYME AND VACCINES CONTAINING THE ENZYMES AND FRAGMENTS THEREOF FOR IMMUNIZING AGAINST BACTERIAL MENINGITIS AND OTHER DISEASES CAUSED BY IgA1 PROTEASE-PRODUCING BACTERIA
09/18/1990WO1990011086A1 Production and use of anthelmintic agents and protective immunogens
09/18/1990US4958009 Anti-human ovarian cancer immunotoxins and methods of use thereof
09/18/1990US4957902 Arginine, glycine, glutamine, tripeptides to tetrapeptides
09/18/1990US4957864 Thromrolytic activity; isolated from a human kidney or blood vessel
09/18/1990US4957742 Method for promoting hair growth
09/18/1990US4957740 Antiinflammatory agents; acne
09/18/1990US4957739 Pharmaceutical compositions of a 105 kD P. Haemolytica derived antigen useful for treatment of Shipping Fever
09/18/1990US4957734 Treatment of certain skin malignancies and pre-malignant skin lesions, herpes zoster and psoriasis
09/18/1990US4957733 Interferon, viricide
09/18/1990CA2305966A1 Productions and use of anthelmintic agents and protective immunogens
09/18/1990CA2050332A1 Human macrophage migration inhibitory factor
09/18/1990CA2049984A1 Immunoglobulin al proteases (iga1 proteases), method of gene-technologically producing this type of enzyme and vaccines containing the enzymes and fragments thereof for immunizingagainst bacterial meningitis and other diseases caused by iga1 protease-producing bacteria
09/18/1990CA1274140A1 Injecting apparatus for emergency treatment
09/17/1990CA2483289A1 Hepatitis c diagnostics and vaccines
09/17/1990CA2012346A1 Mutants of urinary plasminogen activator, their production and use
09/16/1990WO1990010705A2 Production and purification of recombinant human interleukin-3 and muteins thereof
09/16/1990WO1990010647A1 Purified ciliary neurotrophic factor
09/16/1990WO1990010385A1 Cd8-based pharmaceuticals
09/16/1990CA2050346A1 Cd8-based pharmaceuticals
09/16/1990CA2047718A1 Purified ciliary neurotrophic factor
09/16/1990CA2045173A1 Acetylated heterologous polypeptides
09/16/1990CA2028827A1 Production and purification of recombinant human interleukin-3 and muteins thereof
09/16/1990CA2012214A1 Pharmaceutical compositions for the treatment of senile dementia of ischemic or hypoglycemic types
09/16/1990CA2000695A1 Cytokine
09/15/1990WO1990010713A1 Method for stabilizing the hybridization of complementary polynucleotide sequences
09/15/1990WO1990010449A1 Diagnosis and treatment of insulin dependent diabetes mellitus
09/15/1990CA2050913A1 Complementary base sequence hybridization stabilization process
09/15/1990CA2012079A1 Monoclonal antibodies directed against eca and the use thereof
09/14/1990WO1990010460A1 Method for reducing side effects of a drug
09/14/1990CA2055497A1 Method for reducing side effects of a drug
09/13/1990DE4007605A1 New immuno:modulating peptide(s) - comprising tri:peptide serine aspartic acid-lysine with opt. proline, lysine and threonine residues
09/13/1990DE3907822A1 Verwendung einer peroxidaseaktivitaet zeigenden proteinfraktion aus dem photosyntheseapparat von pflanzen als arzneimittel, insbesondere zur krebsbekaempfung, sowie verfahren zur gewinnung einer proteinmischung und arzneimittel zur krebsbekaempfung Using a peroxidase-facing protein fraction from the photosynthetic apparatus of plants as medicine, in particular for krebsbekaempfung, as well as procedures for recovery of a protein mixture and drug-to krebsbekaempfung
09/13/1990DE3907244A1 Erzeugnisse, enthaltend ein lithiumsalz und einen tumor-nekrose-faktor Products containing a lithium salt and a tumor necrosis factor
09/13/1990CA2007962A1 Melanocyte stimulating hormone as dermatitis treatment
09/12/1990EP0387231A2 Novel inhibitors of retroviral protease
09/12/1990EP0387067A1 Novel recombinant DNA and method for production of physiologically active substance
09/12/1990EP0386979A2 DNA encoding ovine-active, growth-hormone-receptor-binding, lactogenic protein
09/12/1990EP0386951A2 An improved diluent formulation for daptomycin
09/12/1990EP0386906A1 Lymphocyte-associated cell surface protein
09/12/1990EP0386882A1 Packaging defective HIV provirus, cell lines, and uses thereof
09/12/1990EP0386752A1 Novel polypeptide and production thereof
09/12/1990EP0386733A1 cDNA coding for placenta protein 9 (PP9), its isolation and its use
1 ... 3028 3029 3030 3031 3032 3033 3034 3035 3036 3037 3038 3039 3040 3041 3042 3043 3044 3045 3046 3047 3048 ... 3163